Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
February 28, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced its expansion into the European...
Absci to Participate in the 43rd Annual Cowen Health Care Conference
February 21, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
February 09, 2023 08:00 ET
|
Absci Corporation
Absci’s generative AI and wet lab capabilities combined with St. John’s Cancer Institute’s molecular database of cancer patient specimens will accelerate the development of immunotherapies. ...
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
February 08, 2023 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the expansion of its Scientific Advisory...
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
January 10, 2023 08:00 ET
|
Absci Corporation
This breakthrough unlocks the potential to accelerate time to clinic by over 50% and increase probability of success in the clinic Creating antibodies in silico with generative AI represents a...
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
January 08, 2023 15:13 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 28, 2022 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci to Participate in the Berenberg Discover AI Seminar
November 23, 2022 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci to Participate in the Piper Sandler Healthcare Conference
November 17, 2022 08:00 ET
|
Absci Corporation
VANCOUVER, Wash. and NEW YORK, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the...
Absci Reports Third Quarter 2022 Financial Results
November 09, 2022 08:00 ET
|
Absci Corporation
Milestone achievement and progress continues in previously announced Merck collaboration Further strengthened executive leadership and Board of Directors VANCOUVER, Wash. and NEW YORK, Nov. 09,...